Literature DB >> 35146576

Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.

Mohammed Jafar1, Mohammed Saifuddin Khalid2, Hajer Alghamdi3, Mohd Amir4, Sarah Aon Al Makki3, Ohud Saud Alotaibi3, Afnan Ali Al Rmais3, Syed Sarim Imam5, Sultan Alshehri6, Sadaf Jamal Gilani7.   

Abstract

The current investigation was performed with an aim to improve the aqueous solubility, dissolution rate, and thus the biological activity of apigenin (APG) using the solubilizers hydroxypropyl beta-cyclodextrin (HPβCD) and chitosan (CTSN). A binary and ternary inclusion complexes of APG with HPβCD and CTSN were prepared by physical mixing, fusion, and solvent evaporation methods. The liquid state characterization of the APG, the solubilizers, and the physical and chemical interactions between them was done through phase solubility approach. The solid-state characterization was performed by proton nuclear magnetic resonance (1H-NMR), differential scanning calorimetry (DSC), and X-ray diffractometry (XRD). The in vitro dissolution test and antioxidant activity and in vivo anti-inflammatory activity of the ternary inclusion complex in albino rats were performed to assess the performance of the APG. Phase solubility study results revealed a remarkable increase in apparent stability constant (Kc) and complexation efficiency (CE) of HPβCD in presence of CTSN in ternary complex with above 8 folds more increment in solubility of APG than its binary complex. The in vitro dissolution rate, antioxidant activity, and the anti-inflammatory effect of the APG ternary inclusion complex were found to be significantly higher than that of pure APG. Solid state characterization confirmed the formation of a ternary inclusion complex. 1H-NMR study gave more insight at molecular level into how different groups of APG were responsible for complex formation with the HPβCD and how CTSN was significantly influencing on the APG-HPβCD complex formed. Nevertheless, pharmacokinetic and histopathological studies of our APG-HPβCD-CTSN ternary complex would yield much rewarding results.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  anti-inflammatory activity; antioxidant activity; apigenin; chitosan; hydroxypropyl-β-cyclodextrin; inclusion complex

Mesh:

Substances:

Year:  2022        PMID: 35146576     DOI: 10.1208/s12249-022-02218-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  26 in total

1.  Design and evaluation of a self-microemulsifying drug delivery system for apigenin.

Authors:  Lili Zhao; Lin Zhang; Lin Meng; Jing Wang; Guangxi Zhai
Journal:  Drug Dev Ind Pharm       Date:  2012-05-21       Impact factor: 3.225

2.  Preparation and in vitro evaluation of apigenin loaded lipid nanocapsules.

Authors:  Buyun Ding; Hao Chen; Chao Wang; Yingjie Zhai; Guangxi Zhai
Journal:  J Nanosci Nanotechnol       Date:  2013-10

Review 3.  Nanonization strategies for poorly water-soluble drugs.

Authors:  Huabing Chen; Chalermchai Khemtong; Xiangliang Yang; Xueling Chang; Jinming Gao
Journal:  Drug Discov Today       Date:  2010-03-03       Impact factor: 7.851

4.  Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.

Authors:  Jianjun Zhang; Yanting Huang; Dapeng Liu; Yuan Gao; Shuai Qian
Journal:  Eur J Pharm Sci       Date:  2013-01-07       Impact factor: 4.384

5.  Simultaneously Improving the Physicochemical Properties, Dissolution Performance, and Bioavailability of Apigenin and Daidzein by Co-Crystallization With Theophylline.

Authors:  Shan Huang; Qian Xue; Jia Xu; Sida Ruan; Ting Cai
Journal:  J Pharm Sci       Date:  2019-04-25       Impact factor: 3.534

Review 6.  Apigenin: A dietary flavonoid with diverse anticancer properties.

Authors:  Josip Madunić; Ivana Vrhovac Madunić; Goran Gajski; Jelena Popić; Vera Garaj-Vrhovac
Journal:  Cancer Lett       Date:  2017-10-31       Impact factor: 8.679

7.  Dose- and time-dependent pharmacokinetics of apigenin trimethyl ether.

Authors:  Mai Gamal Elhennawy; Hai-Shu Lin
Journal:  Eur J Pharm Sci       Date:  2018-03-21       Impact factor: 4.384

8.  Biopharmaceutics classification and intestinal absorption study of apigenin.

Authors:  Jianjun Zhang; Dapeng Liu; Yanting Huang; Yuan Gao; Shuai Qian
Journal:  Int J Pharm       Date:  2012-07-13       Impact factor: 5.875

9.  Ethanol-assisted kneading of apigenin with arginine for enhanced dissolution rate of apigenin: development of rapidly disintegrating tablets.

Authors:  Fatma A Kassem; Abdelaziz E Abdelaziz; Gamal M El Maghraby
Journal:  Pharm Dev Technol       Date:  2021-05-06       Impact factor: 3.133

10.  Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques.

Authors:  Sultan M Alshehri; Faiyaz Shakeel; Mohamed A Ibrahim; Ehab M Elzayat; Mohammad Altamimi; Kazi Mohsin; Osaid T Almeanazel; Musaed Alkholief; Abdullah Alshetaili; Bader Alsulays; Fars K Alanazi; Ibrahim A Alsarra
Journal:  Saudi Pharm J       Date:  2018-11-14       Impact factor: 4.330

View more
  1 in total

1.  Improvement in Solubility-Permeability Interplay of Psoralens from Brosimum gaudichaudii Plant Extract upon Complexation with Hydroxypropyl-β-cyclodextrin.

Authors:  Rúbia Darc Machado; Júlio C G Silva; Luís A D Silva; Gerlon de A R Oliveira; Luciano M Lião; Eliana M Lima; Mariana C de Morais; Edemilson C da Conceição; Kênnia R Rezende
Journal:  Molecules       Date:  2022-07-19       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.